Barclays Maintains Overweight on Celestica, Raises Price Target to $441

Benzinga Newsdesk www.benzinga.com Positive 86.5%

Neg 0% Neu 0% Pos 86.5%

Barclays analyst Tim Long maintains Celestica (NYSE:CLS) with a Overweight and raises the price target from $391 to $441.